SA
Sign upLog In
DSOL

Drug Free Solution, Inc. (DSOL) operates within the healthcare information services sector, focusing on developing digital solutions aimed at substance abuse prevention and treatment. The company's competitive position is bolstered by proprietary technology that integrates behavioral health data analytics with patient management systems, primarily targeting healthcare providers in the United States.

HealthcareHealthcare Information Servicesmoderate - the company has a mix of fixed costs related to technology development and variable costs associated with customer acquisition, allowing for some operational leverage as revenue grows.

Business Overview

01Subscription fees from healthcare providers (estimated 70%)
02Consulting services for implementation and training (estimated 20%)
03Data analytics services (estimated 10%)

DSOL generates revenue through a subscription-based model, providing access to its software platform for healthcare providers. This model allows for predictable revenue streams and scalability. The company benefits from strong pricing power due to its unique technology that enhances treatment outcomes, which is critical for healthcare providers facing regulatory pressures.

What Moves the Stock

Adoption rates of DSOL's technology among healthcare providers

Changes in healthcare regulations impacting substance abuse treatment

Partnerships with larger healthcare systems

Trends in substance abuse rates and public health funding

Watch on Earnings
Monthly active users of the platformCustomer retention rateAverage revenue per user (ARPU)

Risk Factors

Technological disruption from emerging digital health solutions

Regulatory changes affecting healthcare data privacy and security

Increased competition from established healthcare IT firms

Potential entry of tech giants into the healthcare analytics space

Limited cash reserves may hinder growth initiatives

Reliance on external funding for future development

StructuralCompetitiveBalance Sheet

Macro Sensitivity

Economic Cycle

moderate - the company's performance is somewhat linked to healthcare spending, which can be influenced by economic cycles and public health priorities.

Interest Rates

Interest rates can affect DSOL's cost of capital for technology investments and expansion, potentially impacting its valuation multiples if rates rise significantly.

Credit

minimal - the company has no debt, reducing its exposure to credit conditions.

Live Conditions
Russell 2000 FuturesDow Jones FuturesS&P 500 Futures

Profile

growth - investors looking for high-growth potential in the healthcare technology sector.

high - the stock has shown significant volatility, particularly given its recent performance metrics.

Key Metrics to Watch
Healthcare provider adoption rates
Regulatory changes impacting substance abuse treatment
Trends in substance abuse statistics
Customer acquisition costs
Churn rate of existing customers

Explore More

Stock Comparison

Compare equities side by side

52-Week Highs Breakout

Stocks breaking to new annual highs

52-Week Lows Oversold

S&P 500 oversold value screener

Trending Momentum

Relative strength momentum leaders

Earnings Calendar

Upcoming earnings dates & reports

S&P 500 Screener

Filter and sort all 500 stocks

Strategy Focus List

Continuous multi-factor scoring & catalyst forensics

Market Movers

Today's biggest gainers and losers

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.